Janux Therapeutics, Inc. (NASDAQ:JANX), a $2.69 billion market cap biotech firm, noticed its President and CEO David Alan Campbell lately…
Vicki L. Sato, a director at Vir Biotechnology, Inc. (NASDAQ:VIR), has offered a portion of her holdings within the firm.…
Nithrakashyap Arvind (NS:ARVN), Chief Know-how Officer of Rubrik, Inc. (NASDAQ:RBRK), an organization presently valued at $11.92 billion and displaying spectacular…
In a current SEC submitting, Rubrik, Inc. (NASDAQ:RBRK), a cloud knowledge administration firm with a market capitalization of $11.92 billion,…
Brian Ok. McCarthy, the Chief Income Officer of Rubrik, Inc. (NASDAQ:RBRK), lately offered a good portion of his holdings within…
Steve Krognes, a director at Denali Therapeutics Inc. (NASDAQ:DNLI), a $3.05 billion market cap biotech firm with sturdy monetary well…
Alexander Schuth, the Chief Monetary Officer and Secretary of Denali Therapeutics Inc. (NASDAQ:DNLI), a $3.05 billion market cap biotech firm,…
William Hoffman, a director at Inari Medical (TASE:PMCN), Inc. (NASDAQ:NARI), not too long ago bought a good portion of his…
On January 6 and seven, Ryan J. Watts, the President and CEO of Denali Therapeutics Inc. (NASDAQ:DNLI), a $3.05 billion…
Carole Ho, the Chief Medical (TASE:PMCN) Officer of Denali Therapeutics Inc. (NASDAQ:DNLI), has just lately bought shares of the corporate's…